WO2005028430A1 - New process for the preparation of a diphenyl ether compound - Google Patents

New process for the preparation of a diphenyl ether compound Download PDF

Info

Publication number
WO2005028430A1
WO2005028430A1 PCT/IB2004/002989 IB2004002989W WO2005028430A1 WO 2005028430 A1 WO2005028430 A1 WO 2005028430A1 IB 2004002989 W IB2004002989 W IB 2004002989W WO 2005028430 A1 WO2005028430 A1 WO 2005028430A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
reaction
acid
solvent
Prior art date
Application number
PCT/IB2004/002989
Other languages
French (fr)
Inventor
Christopher Paul Ashcroft
Lynsey Charlotte HESMONDHALGH
Lain Robert Gladwell
Laurence James Harris
Michael Leslie Hughs
Juergen Thomas Klotz
Philip Charles Levett
Matthew Charles Morland
Nicholas Murray Thomson
Original Assignee
Pfizer Limited
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0322150A external-priority patent/GB0322150D0/en
Priority claimed from GB0413229A external-priority patent/GB0413229D0/en
Application filed by Pfizer Limited, Pfizer Inc. filed Critical Pfizer Limited
Priority to CA002538115A priority Critical patent/CA2538115A1/en
Priority to EP04769377A priority patent/EP1667963A1/en
Priority to AU2004274245A priority patent/AU2004274245A1/en
Priority to BRPI0414637-9A priority patent/BRPI0414637A/en
Priority to JP2006527501A priority patent/JP2007505940A/en
Publication of WO2005028430A1 publication Critical patent/WO2005028430A1/en
Priority to IL173902A priority patent/IL173902A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Definitions

  • the present invention is concerned with an improved process for the preparation of the selective serotonin reuptake inhibitor 3-
  • WO01/72687 describes the preparation of 3-[(Dimethylamino)methyl]-4-[4- (methylsulfanyl)phenoxy]benzenesulfonamide (L) tartrate (I) in which the compound is prepared by (i) reacting 4-(methylmercapto)phenol (III) with 2- fluorobenzaldehyde (II) in the presence of potassium carbonate in a suitable solvent such as DMF; (ii) carrying out a reductive amination of 2-[4-( ethylsulfanyl)phenoxy]benzaldehyde (IV) with Sodium triacetoxyborohydride and dimethylamine hydrochloride and then optionally forming the HCI salt of the product; (iii) reacting ⁇ /, ⁇ /-Dimethyl- ⁇ /- ⁇ 2-[4-(methylsulfanyl)phenoxy]benzyl ⁇ amine (V) with chlorosulfonic acid in dichloromethane; and (iv) treating 3-[(D
  • Process step (i) is carried out under dilute reaction conditions, the result of which is that a large amount of waste solvent must be disposed of at the end of the reaction. Additionally, when the reaction is carried out on a large scale reaction times are slow. Furthermore, the product of the reaction, compound (IV), is difficult to isolate. It has a low melting point (37-39°C), and therefore the compound is not amenable to drying in a vacuum oven, which makes it difficult to remove the solvent from the product at the end of the reaction. Isolation by crystallisation is also hindered by this property. (b) The reductive amination of compound (IV), process step (ii), proceeds slowly, particularly on a larger scale where reactions can take up to 1 week to reach completion, this has significant economic disadvantages. Furthermore the yields are modest and impurities are generated. The generation of byproducts, such as the primary alcohol derivative of compound (IV), reduces the yield further.
  • step (iii) the chlorosulfonylation of compound (V) is carried out using a large excess of 97% chlorosulfonic acid (10 molar equivalents) in the solvent dichloromethane.
  • the hazardous nature of the reagent and solvent makes them difficult to handle safely, particularly on a large scale.
  • the excess reagent must be neutralised at the end of the reaction generating a large amount of waste.
  • the disposal of large volumes of dichloromethane is also expensive and harmful to the environment.
  • several impurities are generated as by-products in this process step. These impurities have to be carried through to the next step of the sequence due to the highly reactive nature of compound (VI) and its physical form (a sticky solid), which render it difficult to isolate and purify effectively.
  • process step (iv) Due to the moderate purity of compound (VI), process step (iv) is low yielding. Additionally, the sulfonic acid derivative (IX) is generated as a byproduct. Compound (IX) is difficult to separate from the desired product, compound (VII), as are the impurities carried through from process step (iii).
  • compounds of formula (IV) may be prepared by reacting compounds of formula (II) and (III) under the conditions of process step (i), nucleophilic aromatic substitution, in the presence of a base in a suitable solvent.
  • Suitable bases include carbonate bases such as potassium carbonate, sodium carbonate, caesium carbonate; butoxide bases such as potassium t-butoxide, lithium t-butoxide, sodium t-butoxide; hydroxide bases such as sodium hydroxide; and organic bases such as pyridine and morpholine.
  • Suitable solvents include polar aprotic solvents such as N,N- dimethylformamide, tetrahydrofuran, dimethylsulfoxide, dioxan, acetonitrile and ethers.
  • the preferred base for the reaction is potassium carbonate and the preferred solvent is N,N-dimethylformamide.
  • the potassium carbonate is of small particle size (D 90 ⁇ 1000 microns).
  • the resultant compounds of formula (VIII) may be prepared by process step (vi), a reductive amination reaction, by reacting compounds of formula (IV) with a dimethylamine source and a suitable-reducing agent; wherein M is a suitable counter-ion such as chloride, bromide, toluenesulfonate, benzenesulfonate, methane sulfonate, hydrogen sulfate, acetate or trfluororacetate.
  • M is a suitable counter-ion such as chloride, bromide, toluenesulfonate, benzenesulfonate, methane sulfonate, hydrogen sulfate, acetate or trfluororacetate.
  • Suitable sources of dimethylamine include dimethylamine, salts of dimethylamine in the presence of a base (a suitable salt would include hydrochloride, a suitable base would include triethylamine); and N,N- dimethylformamide in the presence of acid or base (a suitable acid would include formic acid; a suitable base would include triethylamine).
  • Suitable reducing agents include sodium borohydride, sodium triacetoxyborohydride, sodium cyanoborohydride, hydrogen gas in the presence of a catalyst, formic acid and formic acid salts such as potassium formate and sodium formate.
  • a Lewis acid such as titanium tetra-iso-propoxide may be beneficial.
  • Suitable solvents for the reaction include dichloromethane, tetrahydrofuran, tert-butylmethylether, ethanol, ethylacetate, N,N-dimethylformamide.
  • the preferred source of reducing agent is formic acid wherein the required dimethylamine is generated by the acid-mediated degradation of N,N- dimethylformamide.
  • N,N-dimethylformamide is the preferred solvent for the reaction.
  • the reaction is preferably carried out at elevated temperature.
  • the intermediate tertiary amine product may then be isolated as a crystalline salt by reacting the amine with a suitable acid in the presence of a suitable solvent.
  • Suitable acids include hydrochloric acid, hydrobromic acid, sulfuric acid, methanesulfonic acid, toluene sulfonic acid, benzenesulfonic acid, acetic acid and trifluororacetic acid.
  • Preferred acids are hydrochloric acid, sulfuric acid and methanesulfonic acid.
  • Suitable solvents include tert-butylmethylether and methylethylketone, either alone, in combination or in the presence of some water.
  • Sulfuric acid salts are particularly preferred. Preferred conditions for their preparation are treatment with methyl ethyl ketone and sulfuric acid. Process steps 1 and 2 may be combined, that is that compounds of formula (IV) are not isolated and purified. This is particularly advantageous as the low melting point of compound (IV) makes it particularly difficult to isolate.
  • compounds of formula (VIII) may be prepared by reacting compounds of formula (II) and (III) under the conditions of process step (i), before treating the crude reaction mixture under the conditions of process step (vi).
  • preferred conditions for process step (i) are N,N- dimethyformamide as solvent and potassium carbonate as base.
  • the potassium carbonate is of small particle size (D go ⁇ 1000 microns).
  • preferred conditions for process step (vi) are N,N- dimethylformamide as solvent and formic acid as reducing agent, at elevated temperature.
  • Compounds of formula (IX) may be prepared by process step (vii), a sulfonylation reaction by reacting compounds of formula (VIII) in the presence of a sulfonylating reagent in the presence of a suitable solvent.
  • Suitable sulfonylating reagents include chlorosulfonic acid, sulfuric acid and fuming sulfuric acid.
  • the preferred sulfonylating agent is chlorosufonic acid (99%).
  • Suitable solvents include dichloromethane, chlorosulfonic acid, trifluoroacetic acid, methanesulfonic acid and sulfuric acid. Preferred solvents are trifluoroacetic acid and methanesulfonic acid.
  • chlorosulfonic acid 99%
  • methanesulfonic acid 99%
  • chlorosulfonic acid 99%
  • trifluoroacetic acid 99%
  • the preferred reaction temperature is between 0-5°C, when trifluoroacetic acid is the solvent.
  • the preferred reaction temperature is 0°C to room temperature, when methansulfonic acid is the solvent.
  • Compounds of formula (VII) may be prepared by process step (viii), formation of a sulfonamide by reacting compounds of formula (IX) with a chlorinating agent in a suitable solvent, before quenching the sulfonyl chloride intermediate with ammonia.
  • Suitable chlorinating agents include PCI 5 , POCI 3 , SOCI 2 and (COCI) 2 .
  • Suitable solvents include acetonitrile, propionitrile, toluene and ethylacetate.
  • Suitable ammonia sources include ammonia gas and a solution of ammonia gas in either an organic solvent or water.
  • Preferred conditions include Phosphorus oxychloride in acetonitrile followed by treatment with aqueous ammonia.
  • Most preferred conditions encompass the addition of the aqueous ammonia to a solution of the intermediate sulfonylchloride (VI), followed by treatment with water.
  • the resultant compound of formula (VII) may be treated with absorbents to enhance its purity. Suitable absorbents include activated charcoal, resins and Fuller's Earth.
  • absorbents include activated charcoal, resins and Fuller's Earth.
  • Compounds of formula (I) may be prepared by process step (ix), by reacting compounds of formula (VII) with D or L Tartaric acid in a solvent system.
  • Suitable solvent systems include iso-propyl alcohol, iso-propyl alcohol /water, Ethanol, ethanol/water, methyl ethyl ketone, methyl ethyl ketone /water, methyl iso-butyl ketone, methyl iso-butyl ketone /water, acetone, acetone/water
  • Most preferred conditions are aqueous (L)-Tartaric acid with methyl ethyl ketone as solvent.
  • Formation of the tartrate salt using the above solvent system gives salts of improved purity in improved yield in a process suitable for an industrial scale.
  • process step (vii) use of 99% chlorosufonic acid (instead of the 97% chlorosufonic acid used in process step (iii)) reduces the amount of by-products generated by more than 50%. Additionally far less sulfonylating reagent is required as compared to process step (iii), therefore there is less chemical waste to dispose of at the end of the reaction. Furthermore, the solvent dichloromethane can be replaced by the more environmentally benign methanesulfonic acid, or trifluoroactectic acid.
  • Compound (IX) is formed as a precipitate from process step (vii).
  • the ability to isolate this product provides a valuable opportunity to purify this intermediate, if necessary, at the mid-point of the reaction sequence. This allows greater control to be exercised with respect to purity during the process.
  • reaction step (viii) The isolation of reactive intermediate compound (VI) is avoided by process step (viii) where it is generated in situ.
  • the reaction conditions employed in this step are milder than those of reaction step (iii) and therefore fewer impurities are generated, improving the purity of the intermediate.
  • NMR spectra were obtained using a Varian Inova 300 MHz spectrometer by dissolving the sample in an appropriate solvent.
  • Mass spectra were obtained using a LC/MS system consisting of an 1100 series Hewlett Packard LC in combination with a Micromass ZMD mass spectrometer.
  • 2-fluorobenzaldehyde (38.0 Kg), 4-(methylmercapto)phenol (43.8 Kg), potassium carbonate (46.6 Kg, with a particle size D 90 ⁇ 1000 microns) and DMF (171 L) were charged to a suitable reactor and heated to 110°C for 24 hours.
  • the reaction mixture was cooled to room temperature, and treated with formic acid (169.1 Kg) over 30 mins.
  • the mixture was heated to 130°C for a further 24 hours and then allowed to cool to room temperature. Water (9.5 L) was added followed by cone, aqueous ammonia (152 L) to adjust the pH to greater than 8.5.
  • the mixture was extracted with TBME (114 L) and the phases allowed to separate, the lower aqueous phase was then discarded.
  • To prepare the sulfate salt the TMBE extract was diluted with MEK (114 L). The solution was cooled to 15°C and concentrated sulphuric acid (30.6 Kg) was added keeping the temperature below 25°C. The mixture was then allowed to cool to 20°C and stirred overnight, finally the mixture was cooled to 0-5°C for 1 hour and the product collected by filtration at reduced pressure. The filter cake was washed with MEK (76 L). The product was then dried at 50°C under vacuum overnight.
  • the title compound may be prepared either using methanesulfonic acid (method A) or trifluoroacetic acid (method B) as solvent.
  • Option 2 The solid product was washed with water (2 x 50 mL).
  • an additional reslurry or recrystallisation may be carried out if necessary.
  • the recrystallisation improves purity to a greater extent than the reslurry and the process is outlined below.
  • Acetonitrile (24.9 L), water (20.75 L) and 3-[(dimethylamino)methyl]-4-[4- (methylthio)phenoxy]benzenesulfonic acid (4.15 Kg) was charged to a vessel and heated to reflux for 1 hour. The resultant solution was then cooled to room temperature over 3 hours and the slurry was stirred overnight at that temperature. The solid was collected by filtration at reduced pressure and the cake was washed with a 1 :1 mixture of acetonitrile and water (4.15 L of each). The material was then dried at 50°C under vacuum overnight.
  • Acetonitrile 60 mL was charged to a vessel and 3-[(dimethylamino)methyl]- 4-[4-(methylthio)phenoxy]benzenesulfonic acid (10.0 g) was added followed by POCI 3 (2.9 mL).
  • the reaction mixture was heated to reflux (approx. 81 °C) for 2 hours.
  • the reaction was monitored by HPLC and was deemed to be complete when starting material was reduced to ⁇ 2%.
  • the reaction mixture was then cooled to -10°C and treated with concentrated aqueous ammonia (60 mL) keeping the temperature below 20°C.
  • the reaction mixture was then treated with further water (60 mL) at 40°C.
  • an optional heat cycle to reflux for 1 hour can be used before cooling to room temperature.
  • Option 1 3-[(Dimethylamino)methyl]-4-[4-(methylthio)phenoxy]benzenesulfonamide (10 g) was mixed with MEK (80 mL) at room temperature. The stirred mixture was heated to reflux (approx. 80°C) for 15 minutes and then cooled to room temperature. The mixture was treated with activated carbon (2O% w/w, 2 g of Cuno 'Pfizer Type A'). The suspension was stirred at room temperature for 15 minutes and then filtered washing the carbon with a further amount of MEK (20 mL).
  • the MEK solution was treated with a solution of ( )-tartaric acid (13.5 Kg) dissolved in water (41.0 L) and MEK (41.1 L) at room temperature over 20 minutes, washing in with a further amount of water (16L) and the resultant slurry was stirred at room temperature for 3 hours.
  • the solid product was then collected by filtration at reduced pressure and the filter cake was washed with MEK (63.3 L).
  • the main peaks (in degrees 2 ⁇ ) of the PXRD pattern are as follows:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is concerned with an improved process for the preparation of the selective serotonin reuptake inhibitor 3-[(Dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzenesulfonamide (L) or (D) tartrate (I) and with intermediate products therein.

Description

NEW PROCESS FOR THE PREPARATION OF A DIPHENYL ETHER COMPOUND
The present invention is concerned with an improved process for the preparation of the selective serotonin reuptake inhibitor 3-
[(Dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzenesulfonamide (L) or (D) tartrate and with intermediate products therein.
WO01/72687 describes the preparation of 3-[(Dimethylamino)methyl]-4-[4- (methylsulfanyl)phenoxy]benzenesulfonamide (L) tartrate (I) in which the compound is prepared by (i) reacting 4-(methylmercapto)phenol (III) with 2- fluorobenzaldehyde (II) in the presence of potassium carbonate in a suitable solvent such as DMF; (ii) carrying out a reductive amination of 2-[4-( ethylsulfanyl)phenoxy]benzaldehyde (IV) with Sodium triacetoxyborohydride and dimethylamine hydrochloride and then optionally forming the HCI salt of the product; (iii) reacting Λ/,Λ/-Dimethyl-Λ/-{2-[4-(methylsulfanyl)phenoxy]benzyl}amine (V) with chlorosulfonic acid in dichloromethane; and (iv) treating 3-[(Dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzenesulfonyI chloride (VI) with aqueous ammonia or ammonia in ethanol to give (VII). Steps (iii) and (iv) may be combined. The corresponding tartrate salt may be obtained by dissolving (VII) in an organic solvent, adding the appropriate tartaric acid, optionally cooling the solution and collecting the resulting crystals of (I).
The complete sequence may be represented as follows:
Figure imgf000003_0001
Figure imgf000003_0002
.H02CCH(OH)CH(OH)C02H
There are a number of problems with this route:
(a) Process step (i) is carried out under dilute reaction conditions, the result of which is that a large amount of waste solvent must be disposed of at the end of the reaction. Additionally, when the reaction is carried out on a large scale reaction times are slow. Furthermore, the product of the reaction, compound (IV), is difficult to isolate. It has a low melting point (37-39°C), and therefore the compound is not amenable to drying in a vacuum oven, which makes it difficult to remove the solvent from the product at the end of the reaction. Isolation by crystallisation is also hindered by this property. (b) The reductive amination of compound (IV), process step (ii), proceeds slowly, particularly on a larger scale where reactions can take up to 1 week to reach completion, this has significant economic disadvantages. Furthermore the yields are modest and impurities are generated. The generation of byproducts, such as the primary alcohol derivative of compound (IV), reduces the yield further.
(c) In process step (iii), the chlorosulfonylation of compound (V) is carried out using a large excess of 97% chlorosulfonic acid (10 molar equivalents) in the solvent dichloromethane. The hazardous nature of the reagent and solvent makes them difficult to handle safely, particularly on a large scale. Furthermore the excess reagent must be neutralised at the end of the reaction generating a large amount of waste. The disposal of large volumes of dichloromethane is also expensive and harmful to the environment. Additionally, several impurities are generated as by-products in this process step. These impurities have to be carried through to the next step of the sequence due to the highly reactive nature of compound (VI) and its physical form (a sticky solid), which render it difficult to isolate and purify effectively.
(d) Due to the moderate purity of compound (VI), process step (iv) is low yielding. Additionally, the sulfonic acid derivative (IX) is generated as a byproduct. Compound (IX) is difficult to separate from the desired product, compound (VII), as are the impurities carried through from process step (iii).
In summary, whilst this reaction sequence provides an adequate route for the production of compounds of formula (I) on a laboratory scale, there is a clear requirement for a robust process that would be more applicable to industrial scale generation of these compounds. As a result an improved synthetic process has been developed to 3- [(Dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzenesulfonamide (L) or (D) tartrate (I) which overcomes the problems described above.
The complete sequence may be represented as follows:
Figure imgf000005_0001
Figure imgf000005_0002
.H02CCH(OH)CH(OH)C02H
In one embodiment of the invention compounds of formula (IV) may be prepared by reacting compounds of formula (II) and (III) under the conditions of process step (i), nucleophilic aromatic substitution, in the presence of a base in a suitable solvent. Suitable bases include carbonate bases such as potassium carbonate, sodium carbonate, caesium carbonate; butoxide bases such as potassium t-butoxide, lithium t-butoxide, sodium t-butoxide; hydroxide bases such as sodium hydroxide; and organic bases such as pyridine and morpholine.
Suitable solvents include polar aprotic solvents such as N,N- dimethylformamide, tetrahydrofuran, dimethylsulfoxide, dioxan, acetonitrile and ethers.
The preferred base for the reaction is potassium carbonate and the preferred solvent is N,N-dimethylformamide.
Most preferably the potassium carbonate is of small particle size (D90 <1000 microns).
The resultant compounds of formula (VIII) may be prepared by process step (vi), a reductive amination reaction, by reacting compounds of formula (IV) with a dimethylamine source and a suitable-reducing agent; wherein M is a suitable counter-ion such as chloride, bromide, toluenesulfonate, benzenesulfonate, methane sulfonate, hydrogen sulfate, acetate or trfluororacetate.
Suitable sources of dimethylamine include dimethylamine, salts of dimethylamine in the presence of a base (a suitable salt would include hydrochloride, a suitable base would include triethylamine); and N,N- dimethylformamide in the presence of acid or base (a suitable acid would include formic acid; a suitable base would include triethylamine).
Suitable reducing agents include sodium borohydride, sodium triacetoxyborohydride, sodium cyanoborohydride, hydrogen gas in the presence of a catalyst, formic acid and formic acid salts such as potassium formate and sodium formate. In some cases addition of a Lewis acid such as titanium tetra-iso-propoxide may be beneficial.
Suitable solvents for the reaction include dichloromethane, tetrahydrofuran, tert-butylmethylether, ethanol, ethylacetate, N,N-dimethylformamide.
The preferred source of reducing agent is formic acid wherein the required dimethylamine is generated by the acid-mediated degradation of N,N- dimethylformamide.
N,N-dimethylformamide is the preferred solvent for the reaction.
The reaction is preferably carried out at elevated temperature.
The intermediate tertiary amine product may then be isolated as a crystalline salt by reacting the amine with a suitable acid in the presence of a suitable solvent.
Suitable acids include hydrochloric acid, hydrobromic acid, sulfuric acid, methanesulfonic acid, toluene sulfonic acid, benzenesulfonic acid, acetic acid and trifluororacetic acid.
Preferred acids are hydrochloric acid, sulfuric acid and methanesulfonic acid.
Suitable solvents include tert-butylmethylether and methylethylketone, either alone, in combination or in the presence of some water.
Sulfuric acid salts are particularly preferred. Preferred conditions for their preparation are treatment with methyl ethyl ketone and sulfuric acid. Process steps 1 and 2 may be combined, that is that compounds of formula (IV) are not isolated and purified. This is particularly advantageous as the low melting point of compound (IV) makes it particularly difficult to isolate.
Accordingly in one embodiment of the invention compounds of formula (VIII) may be prepared by reacting compounds of formula (II) and (III) under the conditions of process step (i), before treating the crude reaction mixture under the conditions of process step (vi).
In this embodiment, preferred conditions for process step (i) are N,N- dimethyformamide as solvent and potassium carbonate as base.
Most preferably the potassium carbonate is of small particle size (Dgo <1000 microns).
In this embodiment, preferred conditions for process step (vi) are N,N- dimethylformamide as solvent and formic acid as reducing agent, at elevated temperature.
According to another embodiment of the invention Compounds of formula (IX) may be prepared by process step (vii), a sulfonylation reaction by reacting compounds of formula (VIII) in the presence of a sulfonylating reagent in the presence of a suitable solvent.
Suitable sulfonylating reagents include chlorosulfonic acid, sulfuric acid and fuming sulfuric acid.
The preferred sulfonylating agent is chlorosufonic acid (99%).
Suitable solvents include dichloromethane, chlorosulfonic acid, trifluoroacetic acid, methanesulfonic acid and sulfuric acid. Preferred solvents are trifluoroacetic acid and methanesulfonic acid.
Most preferred conditions are chlorosulfonic acid (99%) and methanesulfonic acid or chlorosulfonic acid (99%) and trifluoroacetic acid.
The preferred reaction temperature is between 0-5°C, when trifluoroacetic acid is the solvent. The preferred reaction temperature is 0°C to room temperature, when methansulfonic acid is the solvent.
According to yet another embodiment of the invention Compounds of formula (VII) may be prepared by process step (viii), formation of a sulfonamide by reacting compounds of formula (IX) with a chlorinating agent in a suitable solvent, before quenching the sulfonyl chloride intermediate with ammonia.
Suitable chlorinating agents include PCI5, POCI3, SOCI2 and (COCI)2.
Suitable solvents include acetonitrile, propionitrile, toluene and ethylacetate.
Suitable ammonia sources include ammonia gas and a solution of ammonia gas in either an organic solvent or water.
Preferred conditions include Phosphorus oxychloride in acetonitrile followed by treatment with aqueous ammonia.
Most preferred conditions encompass the addition of the aqueous ammonia to a solution of the intermediate sulfonylchloride (VI), followed by treatment with water.
In a further embodiment of the invention, the resultant compound of formula (VII) may be treated with absorbents to enhance its purity. Suitable absorbents include activated charcoal, resins and Fuller's Earth. According to yet another embodiment of the invention Compounds of formula (I) may be prepared by process step (ix), by reacting compounds of formula (VII) with D or L Tartaric acid in a solvent system.
Suitable solvent systems include iso-propyl alcohol, iso-propyl alcohol /water, Ethanol, ethanol/water, methyl ethyl ketone, methyl ethyl ketone /water, methyl iso-butyl ketone, methyl iso-butyl ketone /water, acetone, acetone/water
Most preferred conditions are aqueous (L)-Tartaric acid with methyl ethyl ketone as solvent.
Formation of the tartrate salt using the above solvent system gives salts of improved purity in improved yield in a process suitable for an industrial scale.
The advantages of this new process may be summarised as follows:
i) The use of potassium carbonate of particle size D90 <1000 microns, reduces the reaction time required for process step (i) to reach completion when carried out on a large scale. The use of this reagent facilitates the completion of multi-kilo reactions in less than 24 hours; this has significant economic advantages.
ii) The use of N,N-dimethylformamide as both solvent and dimethylamine source in process step (vi) allows the combination of process steps (i) and (vi) to be possible. The combination of process steps (i) and (vi) avoids the isolation of low melting intermediate compound (IV) and also significantly reduces the volume of solvent required for these two transformations. Reaction efficiency is thus increased as more product is generated from a smaller reaction volume. iii) The use of formic acid as reducing agent in process step (vi) is particularly advantageous for two reasons. Firstly, as it is a liquid, it can be added in a controlled fashion to the reaction mixture at the end of process step (i). Therefore the gas evolution that accompanies the pH change between process steps (i) and (vi) can be managed safely. Secondly, the oxidation of formic acid does not generate any chemical waste; CO2 is the sole by product.
iv) The purity of compound (VIII) is increased by the formation of its preferred sulphate salt during process step (vi). This salt form is easily isolated from the reaction mixture at the end of the reaction.
v) In process step (vii), use of 99% chlorosufonic acid (instead of the 97% chlorosufonic acid used in process step (iii)) reduces the amount of by-products generated by more than 50%. Additionally far less sulfonylating reagent is required as compared to process step (iii), therefore there is less chemical waste to dispose of at the end of the reaction. Furthermore, the solvent dichloromethane can be replaced by the more environmentally benign methanesulfonic acid, or trifluoroactectic acid.
vi) Compound (IX) is formed as a precipitate from process step (vii). The ability to isolate this product provides a valuable opportunity to purify this intermediate, if necessary, at the mid-point of the reaction sequence. This allows greater control to be exercised with respect to purity during the process.
vii) The isolation of reactive intermediate compound (VI) is avoided by process step (viii) where it is generated in situ. The reaction conditions employed in this step are milder than those of reaction step (iii) and therefore fewer impurities are generated, improving the purity of the intermediate.
viii) The subsequent quenching of this intermediate is carried out in a novel fashion by the addition of aqueous ammonia to the reaction mixture, followed by the addition of water and carrying out an in situ reflux. Accepted industrial scale practice in the art would be to add the reaction mixture to an excess of aqueous ammonia. This new, reversed mode of addition has the following advantages: (a) The by-product sulfonic acid derivative (IX) is soluble in the reaction mixture which facilitates its removal from the product. (b) It is not necessary to transfer the slurry of intermediate compound (VI) to another reaction vessel, thereby avoiding the handling problems associated with its physical form. (c) The reflux increases the solubility of the inorganic impurities in the reaction mixture, and therefore aids their separation from the product. In addition, organic impurities are purged.
The above advantages result in a higher yield of compound (VII).
ix) This new process is suitable for producing quantities of compound (I) on an industrial scale.
In a further embodiment of the present invention are provided compounds of formula (VIII) and (IX) wherein M is a suitable counter-ion as described above.
Figure imgf000012_0001
These compounds are particularly useful in the synthesis of compounds of formula (I) by the process of the present invention.
Experimental
The following abbreviations and definitions are used:
MEK methylethyl ketone DMF N, /V-dimethylformamide
TBME te/f/aty-butyl methyl ether
DMSO dimethylsulfoxide
POCI3 phosphorousoxychloride
DCM dichloromethane
DMSO dimethylsulfoxide m/z mass spectrum peak
HPLC High Pressure Liquid Chromi
MS mass spectrum
NMR nuclear magnetic resonance q quartet s singlet t triplet br broad
TFA trifluoroacetic acid
MSA Methanesulfonic acid
Kg Kilograms
L Litre mL millilitre g grams
CDCI3 deuterated chloroform
The powder X-ray diffraction (PXRD) patterns were determined using a Siemens D5000 powder X-ray diffractometer fitted with a theta-theta goniometer, automatic beam divergence slits, a secondary monochromator and a scintillation counter. The specimen was rotated whilst being irradiated with copper K-aipha1 X-rays (Wavelength = 1.5046 Angstroms) filtered with a graphite monochromator (λ = 0.15405nm) with the X-ray tube operated at 40 kV/40mA. The main peaks (in degrees 2Θ) of the PXRD patterns for the various solid forms are illustrated. Melting points were determined using either a Perkin Elmer DSC7 at a heating rate of 20°C/minute or a Buchi melting point B-545.
NMR spectra were obtained using a Varian Inova 300 MHz spectrometer by dissolving the sample in an appropriate solvent.
Mass spectra were obtained using a LC/MS system consisting of an 1100 series Hewlett Packard LC in combination with a Micromass ZMD mass spectrometer.
/V,/V-dimethyl-2-[4-(methylthio)phenoxy1benzylaminehvdrogen sulfate
Figure imgf000014_0001
2-fluorobenzaldehyde (38.0 Kg), 4-(methylmercapto)phenol (43.8 Kg), potassium carbonate (46.6 Kg, with a particle size D90 <1000 microns) and DMF (171 L) were charged to a suitable reactor and heated to 110°C for 24 hours. When all the 2-fluorobenzaldehyde was consumed (<3% as evidenced by HPLC) the reaction mixture was cooled to room temperature, and treated with formic acid (169.1 Kg) over 30 mins. The mixture was heated to 130°C for a further 24 hours and then allowed to cool to room temperature. Water (9.5 L) was added followed by cone, aqueous ammonia (152 L) to adjust the pH to greater than 8.5. The mixture was extracted with TBME (114 L) and the phases allowed to separate, the lower aqueous phase was then discarded. To prepare the sulfate salt the TMBE extract was diluted with MEK (114 L). The solution was cooled to 15°C and concentrated sulphuric acid (30.6 Kg) was added keeping the temperature below 25°C. The mixture was then allowed to cool to 20°C and stirred overnight, finally the mixture was cooled to 0-5°C for 1 hour and the product collected by filtration at reduced pressure. The filter cake was washed with MEK (76 L). The product was then dried at 50°C under vacuum overnight. Yield = 81%, δH (DMSO-d6, 300 MHz) 2.48 (6H, s), 2.81 (3H, s), 4.39 (2H, s), 6.82 (1 H, d), 7.05 (2H, d), 7.22 (1 H, t), 7.39 (2H, d), 7.43 (1 H, t), 7.61 (1 H, d), 9.46 (1 H, br, s); MS m/z (TS+) 274 (MH+), Melting point = 139-141°C.
3-r(dimethylamino)methvπ-4-f4-(methylthio)phenoxylbenzenesulfonic acid
Figure imgf000015_0001
The title compound may be prepared either using methanesulfonic acid (method A) or trifluoroacetic acid (method B) as solvent.
Method A.
To a suitable vessel methanesulfonic acid (17.66 L) was charged followed by Λ/,Λ/-dimethyl-2-[4-(methylthio)phenoxy]benzylaminehydrogen sulfate (7.85 Kg), the mixture was stirred at room temperature until a solution was achieved. The reaction mixture was cooled to 0°C and treated with chlorosulfonic acid (11.36 Kg), keeping temperature below 5°C, over 1 hour. The reaction was monitored by HPLC and the reaction was complete after 5 hours with <2% starting material detected. In a separate vessel water (70.65 Kg) was cooled to 5°C. The cooled reaction mixture was then quenched into the cooled water keeping the temperature below 35°C. A thick white precipitate was formed during the quench. Finally wash the remaining reaction mixture into the quench with methanesulfonic acid (2.91 Kg), then water (7.85 Kg). The resultant slurry was stirred overnight at room temperature before cooling to 0°C for 1 hour. The product was filtered under reduced pressure and the cake washed with water (15.7 L). The solid product was then stirred with water (78.5 L) at room temperature for 1 hour. The product was filtered at reduced pressure and the cake washed with water (15.7 L). The material was then dried at 50°C under vacuum overnight. Yield = 62%.
Method B.
To a suitable vessel trifluoroacetic acid (138 mL) was charged followed by N,N- dimethyl-2-[4-(methylthio)phenoxy]benzylaminehydrogen sulfate (50 g), the mixture was stirred at -3°C until a solution was achieved. The reaction mixture was maintained at -3°C and treated with chlorosulfonic acid (36 mL) while keeping the temperature below 6°C, over 0.25 hour. Using 99% grade chlorosulfonic acid minimises impurity generation in the reaction (compared to lower grades of reagent) and the resulting solid is therefore isolated with increased purity. The reaction was monitored by HPLC and the reaction was complete after 24 hours with <2% starting material detected. In a separate vessel water (500 mL) was cooled to 2°C. The reaction mixture was then quenched into the cooled water (over 2.5 mins) keeping the temperature below 27°C. The fast addition is necessary to keep the product in solution until the end of the addition, at which time the product begins to slowly precipitate out, and the largest crystal size is observed. The reaction mixture was washed into the quenched mixture with trifluoroacetic acid (12 mL) and the slurry was stirred at 20°C for 2.5 hour, and then at 0°C overnight. The product was filtered under reduced pressure. Several options are available for upgrading the quality of the material before drying.
Option 1 The solid product was stirred in water (250 mL) at room temperature for 0.5 hour and then filtered at reduced pressure. The solid was stirred in a 1 :1 mixture of acetonitrile/water (250 mL) for 2 hours at 40°C. The slurry was cooled to room temperature and after 1 hour, filtered under reduced pressure. The 1 :1 acetonitrile/water (250 mL) reslurry at 40°C was repeated once more on the damp product and then dried at 50°C under vacuum overnight. Yield = 54%. Option 2 The solid product was washed with water (2 x 50 mL). The solid was then stirred in a 1 :1 mixture of acetonitrile/water (250 mL) at 60°C for 1 hour. The slurry was cooled to room temperature and stirred at this temperature for 4 hours. The product was filtered under reduced pressure and then dried at 50°C under vacuum overnight. Yield = 55%.
Option 3 The solid was then stirred in a 1 :1 mixture of acetonitrile/water (250 mL) at 60°C for 1 hour. The slurry was cooled to room temperature and stirred at this temperature for 4 hours. The product was filtered under reduced pressure and then dried at 50°C under vacuum overnight. Yield = 58%.
To further upgrade the purity of this key intermediate an additional reslurry or recrystallisation may be carried out if necessary. The recrystallisation improves purity to a greater extent than the reslurry and the process is outlined below.
Acetonitrile (24.9 L), water (20.75 L) and 3-[(dimethylamino)methyl]-4-[4- (methylthio)phenoxy]benzenesulfonic acid (4.15 Kg) was charged to a vessel and heated to reflux for 1 hour. The resultant solution was then cooled to room temperature over 3 hours and the slurry was stirred overnight at that temperature. The solid was collected by filtration at reduced pressure and the cake was washed with a 1 :1 mixture of acetonitrile and water (4.15 L of each). The material was then dried at 50°C under vacuum overnight. Yield = 72%, 5H (DMSO-de, 300 MHz) 2.52 (3H, s), 2.80 (6H, s), 4.40 (2H, d), 6.78 (1 H, d), 7.04 (2H, d), 7.18 (2H, d), 7.62 (1 H, d), 7.93 (1 H, s), 9.55 (1 H, br, s); MS m/z (TS") 352 (MH").
3-|"(Dimethylamino)methyπ-4-[4-(methylthio)phenoxy1benzenesulfonamide.
Figure imgf000017_0001
Acetonitrile (60 mL) was charged to a vessel and 3-[(dimethylamino)methyl]- 4-[4-(methylthio)phenoxy]benzenesulfonic acid (10.0 g) was added followed by POCI3 (2.9 mL). The reaction mixture was heated to reflux (approx. 81 °C) for 2 hours. The reaction was monitored by HPLC and was deemed to be complete when starting material was reduced to <2%. The reaction mixture was then cooled to -10°C and treated with concentrated aqueous ammonia (60 mL) keeping the temperature below 20°C. The reaction mixture was then treated with further water (60 mL) at 40°C. Here an optional heat cycle to reflux for 1 hour can be used before cooling to room temperature. The optional heat cycle affords a higher level of purging of process related impurities. The reaction mixture was stirred overnight at room temperature. The resultant solid was filtered at reduced pressure and the filter cake washed with water (20 mL) before being dried at 50°C under vacuum overnight. Yield = 88%. δH (CDCI3, 300 MHz) 2.35 (6H, s), 2.49 (3H, s), 3.66 (2H, s), 5.20 (2H, br), 6.81 (1 H, d), 6.92 (2H, d), 7.27 (2H, d), 7.72 (1 H, dd), 8.14 (1 H, d); MS m/z (TS+) 353 (MH+).
3-r(dimethylamino)methyll-4-r4-methylthio)phenoxy1benzenesulfonamide ( RHartrate.
Figure imgf000018_0001
There are two options for preparing 3-[(dimethylamino)methyl]-4-[4- methylthio)phenoxy]benzenesulfonamide ( R)-tartrate depending on whether activated carbon is used in a loose or solid supported form.
Option 1 3-[(Dimethylamino)methyl]-4-[4-(methylthio)phenoxy]benzenesulfonamide (10 g) was mixed with MEK (80 mL) at room temperature. The stirred mixture was heated to reflux (approx. 80°C) for 15 minutes and then cooled to room temperature. The mixture was treated with activated carbon (2O% w/w, 2 g of Cuno 'Pfizer Type A'). The suspension was stirred at room temperature for 15 minutes and then filtered washing the carbon with a further amount of MEK (20 mL). The MEK solution was treated with a solution of ( )-tartaric acid (4.26 g) dissolved in water (13 mL) and MEK (13mL) at room temperature over 10 minutes and the resultant slurry was stirred at room temperature for 1 hour. The solid product was then collected by filtration at reduced pressure and the filter cake was washed with MEK (20 mL). The salt was dried at 50°C under vacuum. Yield = 82%.
Option 2
3-[(Dimethylamino)methyl]-4-[4-(methylthio)phenoxy]benzenesulfonamide (31.65 Kg) was mixed with MEK (253.2 L) at room temperature. The stirred mixture was heated to reflux (approx. 80°C) for 1 hour and then cooled to room temperature. The mixture was clarified by filtration at reduced pressure. The solution was passed through a solid supported activated carbon cartridge at 10-12 L/minute (0.5 g/cm2 carbon surface area, of Cuno 'R50Sp Pfizer Type A'). MEK (95L) was used to wash the filter cake followed by the solid supported carbon cartridge. The MEK solution was treated with a solution of ( )-tartaric acid (13.5 Kg) dissolved in water (41.0 L) and MEK (41.1 L) at room temperature over 20 minutes, washing in with a further amount of water (16L) and the resultant slurry was stirred at room temperature for 3 hours. The solid product was then collected by filtration at reduced pressure and the filter cake was washed with MEK (63.3 L). The salt was then dried at 50°C under vacuum. Yield = 87%.
The main peaks (in degrees 2Θ) of the PXRD pattern are as follows:
Figure imgf000020_0001

Claims

Claims
1 A process for the preparation of a compound of formula (I):
Figure imgf000021_0001
.H02CCH(OH)CH(OH)C02H
comprising the reaction of a compound of formula (VII)
Figure imgf000021_0002
with tartaric acid in a suitable solvent.
2 A process according to claim 1 where the solvent is methyl ethyl ketone and the (L) form of tartaric acid is used.
3 A process according to claim 1 which further comprises the preparation of a compound of formula (VII) by reaction of a compound of formula (IX)
Figure imgf000021_0003
with a suitable chlorinating agent, in a suitable solvent, to generate a sulfonyl chloride in situ; and then quenching this sulfonyl chloride by addition of a suitable ammonia source to the reaction mixure.
4 A process according to claim 3 which further comprises the preparation of a compound of formula (IX) by the reaction of a compound of formula (VIII)
Figure imgf000022_0001
wherein M is a suitable counter-ion, with a suitable sulfonylating agent in a suitable solvent.
5 A process according to claim 4 where the solvent is methanesulfonic acid or trifluoroacetic acid and M is the chloride, hydrogensulfate, or methanesulfonate ion.
6 A process according to claim 4 which further comprises the preparation of a compound of formula (VIII) by the reaction of a compound of formula (IV)
Figure imgf000022_0002
with a suitable dimethylamine source in the presence of a suitable reducing agent, in a suitable solvent and then treating the resultant amine with a suitable acid. 7 A process according to claim 6 where the reducing agent is formic acid and the solvent is N,N-dimethylformamide.
8 A process according to claim 6 which further comprises the preparation of a compound of formula (IV) by the reaction of a compound of formula (II)
Figure imgf000023_0001
(ID
with a compound of formula (III)
Figure imgf000023_0002
in the presence of a suitable base, in a suitable solvent.
9 A process, according to claim 8, for the preparation of a compound of formula (VIII) wherein: (i) the reaction of compounds (II) and (III) is carried out in N,N- di ethylformamide in the presence a base; (ii) the resultant crude reaction mixture containing compound (IV) is treated with formic acid and then allowed to react at elevated temperature; (iii) the salt of the resulting amine product is formed by treatment with an appropriate acid. 10 A process for the preparation of a compound of formula (VII):
Figure imgf000024_0001
comprising reaction of a compound of formula (IX)
Figure imgf000024_0002
with a suitable chlorinating agent, in a suitable solvent, to generate a sulfonyl chloride in situ; and then quenching this sulfonyl chloride by addition of a suitable ammonia source to the reaction mixure.
11 A process for the preparation of a compound of formula (IX):
Figure imgf000024_0003
comprising the reaction of a compound of formula (VIII)
Figure imgf000024_0004
wherein Ivl is the chloride, hydrogensulfate, or methanesulfonate ion, with a suitable sulfonylating agent in a methanesulfonic acid or trifluoroacetic acid as solvent.
12 A process for the preparation of a compound of formula (VIII)
Figure imgf000025_0001
wherein Ivl is a suitable counter-ion; comprising the reaction of a compound of formula (IV)
Figure imgf000025_0002
with a suitable dimethylamine source in the presence of a suitable reducing agent, in a suitable solvent and then treating the resultant amine with a suitable acid.
13 A compound of formula (IX):
Figure imgf000025_0003
4 A compound of formula (VIII):
Figure imgf000026_0001
wherein M is the hydrogensulfate or methanesulfonate ion.
PCT/IB2004/002989 2003-09-22 2004-09-10 New process for the preparation of a diphenyl ether compound WO2005028430A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002538115A CA2538115A1 (en) 2003-09-22 2004-09-10 New process for the preparation of a diphenyl ether compound
EP04769377A EP1667963A1 (en) 2003-09-22 2004-09-10 New process for the preparation of a diphenyl ether compound
AU2004274245A AU2004274245A1 (en) 2003-09-22 2004-09-10 New process for the preparation of a diphenyl ether compound
BRPI0414637-9A BRPI0414637A (en) 2003-09-22 2004-09-10 process for the preparation of a diphenyl ether compound
JP2006527501A JP2007505940A (en) 2003-09-22 2004-09-10 New production method of biphenyl ether compounds
IL173902A IL173902A0 (en) 2003-09-22 2006-02-23 New process for the preparation of a diphenyl ether compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0322150A GB0322150D0 (en) 2003-09-22 2003-09-22 New process for the preparation of a biphenyl ether compound
GB0322150.4 2003-09-22
GB0413229A GB0413229D0 (en) 2004-06-14 2004-06-14 New process for the preparation of a biphenyl ether compound
GB0413229.6 2004-06-14

Publications (1)

Publication Number Publication Date
WO2005028430A1 true WO2005028430A1 (en) 2005-03-31

Family

ID=34379492

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/002989 WO2005028430A1 (en) 2003-09-22 2004-09-10 New process for the preparation of a diphenyl ether compound

Country Status (10)

Country Link
EP (1) EP1667963A1 (en)
JP (1) JP2007505940A (en)
KR (1) KR20060070566A (en)
AR (1) AR045790A1 (en)
AU (1) AU2004274245A1 (en)
BR (1) BRPI0414637A (en)
CA (1) CA2538115A1 (en)
IL (1) IL173902A0 (en)
TW (1) TWI247735B (en)
WO (1) WO2005028430A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5116349B2 (en) * 2007-04-18 2013-01-09 株式会社ダイセル Method for producing vinyl ether compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072687A1 (en) * 2000-03-31 2001-10-04 Pfizer Limited Diphenyl ether compounds useful in therapy
US20020143003A1 (en) * 1999-02-23 2002-10-03 Howard Harry R. Monoamine reuptake inhibitors for treatment of CNS disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020143003A1 (en) * 1999-02-23 2002-10-03 Howard Harry R. Monoamine reuptake inhibitors for treatment of CNS disorders
WO2001072687A1 (en) * 2000-03-31 2001-10-04 Pfizer Limited Diphenyl ether compounds useful in therapy

Also Published As

Publication number Publication date
AR045790A1 (en) 2005-11-16
AU2004274245A1 (en) 2005-03-31
IL173902A0 (en) 2006-07-05
TWI247735B (en) 2006-01-21
TW200526560A (en) 2005-08-16
JP2007505940A (en) 2007-03-15
EP1667963A1 (en) 2006-06-14
BRPI0414637A (en) 2006-11-14
KR20060070566A (en) 2006-06-23
CA2538115A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
TWI774791B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
KR102396059B1 (en) Novel compound and method for preparing same
ES2960509T3 (en) Intermediates for optically active piperidine derivatives and methods of preparation thereof
PL212886B1 (en) Method of obtaining 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f]thiazepine and application thereof in thianeptin synthesising process
EP2479166A1 (en) A process for the preparation of etoricoxib
EP1667963A1 (en) New process for the preparation of a diphenyl ether compound
US20050119504A1 (en) New process for the preparation of a biphenyl ether compound
MXPA06003215A (en) New process for the preparation of a diphenyl ether compound
EP3262031A1 (en) Process for the preparation of vortioxetine
CN110655466B (en) Preparation method of benzphetamine hydrochloride
JP6260385B2 (en) Method for producing 2-hydroxymethyl-2,3-dihydro-thieno [3,4-b] [1,4] dioxin-5,7-dicarboxylic acid dialkyl ester
EP2480535A1 (en) Polymorphs of sorafenib acid addition salts
CN109206373B (en) Preparation process of palbociclib intermediate 5-bromo-2-chloro-4-cyclopentylamino pyrimidine
CA2545119A1 (en) A process for the manufacture of zonisamide
Carlsen Benzylation of alcohols and phenols with N-(4-methoxybenzyl)-o-benzenedisulfonimide
TWI844663B (en) Process for the production of substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives
JP7389761B2 (en) One-pot organo-pseudocatalytic C-H activation method for preparing vortioxetine and vortioxetine intermediates
JPH04169583A (en) Phenothiazine derivative and its production
EP2776414B1 (en) Method for preparing cyclopropane derivatives
Xia et al. A convenient synthesis of N, N, N'-trisubstituted ethylenediamine derivatives from 2-methyl-2-imidazoline
CN115385840A (en) Process for preparing 3-methoxyazetidine hydrochloride
JPWO2010029756A1 (en) Process for producing 5- [2- (methylthio) ethoxy] pyrimidin-2-amine
CN114478336A (en) Process for producing mercaptophenol compound and intermediate therefor
ITMI20011162A1 (en) HALOGENARYLSULPHONAMIDES WITH ANTI-TUMOR CHARACTERISTICS
WO2006008635A1 (en) Process for the preparation of a 3-phenoxy-pyridine derivative

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480027310.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 173902

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 1050/DELNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2538115

Country of ref document: CA

Ref document number: 2004274245

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 12006500540

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 1020067005573

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2006527501

Country of ref document: JP

Ref document number: PA/a/2006/003215

Country of ref document: MX

Ref document number: 06028470

Country of ref document: CO

ENP Entry into the national phase

Ref document number: 2004274245

Country of ref document: AU

Date of ref document: 20040910

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004274245

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004769377

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1200600633

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 2006109008

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2004769377

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020067005573

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0414637

Country of ref document: BR

WWR Wipo information: refused in national office

Ref document number: 1020067005573

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 2004769377

Country of ref document: EP